Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

RATIONALE: Restenosis due to intimal hyperplasia (IH) is a major clinical issue that affects the success of lower limb endovascular surgery. After 1 year, restenosis occurs in 40% to 60% of the treated vessels. The possibility to reduce IH using local antiproliferative drugs, such as taxols, has been the rationale for the clinical applications of drug-eluting stents and drug-eluting balloons (DEBs). The purpose of this study was to evaluate the clinical and instrumental efficacy of DEBs versus simple percutaneous transluminal angioplasty (PTA) in patients affected by chronic limb ischemia (CLI) with tibial artery "de novo" lesions. METHODS: A retrospective analysis was performed and included all consecutive patients who underwent endovascular treatment for CLI in our centers between January 2011 and March 2013. Inclusion criteria were (1) "de novo" tibial artery stenosis and (2) Rutherford class >4. Lesions were further divided by TransAtlantic Inter-Societal Consensus (TASC) classification into groups A, B, C, and D. RESULTS: Between January 2010 and March 2013, a total of 138 patients underwent simple PTA or DEB for CLI, and the groups were clinically and demographically homogenous. We decided to use DEBs in 70 cases. An improvement in the Rutherford Scale in cumulative and single TASC lesions classification was better in the DEB group (74% vs 51%; P = .024) at 24 months than in the PTA group. In the DEB group, the increase in ankle-brachial index was significantly higher than in the PTA group (P = .039). CONCLUSIONS: Our experience in addition to the existing literature supports the use of DEB in patients with CLI Rutherford class >3.

Original publication




Journal article


Vasc Endovascular Surg

Publication Date





304 - 308


drug-eluting balloon, intimal hyperplasia, restenosis, Aged, Amputation, Angioplasty, Balloon, Ankle Brachial Index, Cardiovascular Agents, Coated Materials, Biocompatible, Equipment Design, Europe, Female, Humans, Hyperplasia, Ischemia, Limb Salvage, Lower Extremity, Male, Middle Aged, Neointima, Peripheral Arterial Disease, Recurrence, Retrospective Studies, Tibial Arteries, Time Factors, Treatment Outcome, Vascular Access Devices